event tracking

Research

511 results.

October 11, 2017 Stand Up To Cancer awards $5.5 million to VARI for cancer clinical trials to enhance immunotherapy

GRAND RAPIDS, Mich. (Oct. 12, 2017)—Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team (VARI-SU2C) scientists have been awarded two…

VAI DEFAULT HEADER
October 11, 2017 A Catalyst for combating cancer

Nearly $5.5 million in grant funding to fuel collaborative clinical trials in lung and bladder cancers By Dr. Peter Jones and Dr. Steve Baylin Co-leaders,…

VAI DEFAULT HEADER
October 4, 2017 Miss Grand Challenges in Parkinson’s Disease and Rallying to the Challenge? We have you covered.

From exploring possible new treatments to discussing how people with Parkinson’s can influence research, last week’s Grand Challenges in Parkinson’s Disease symposium…

VAI DEFAULT HEADER
September 26, 2017 Pioneering scientist wins annual Jay Van Andel Award

GRAND RAPIDS, Mich. (Sept. 27, 2017) — Van Andel Research Institute announces pioneering physician-scientist J. William Langston, M.D., as the 2017 winner of the

VAI DEFAULT HEADER
September 26, 2017 Award honors Parkinson’s pioneer

GRAND RAPIDS, Mich. (Sept. 27, 2017) — Van Andel Research Institute and The Cure Parkinson’s Trust announce Thomas Foltynie, B.Sc., MBBS, MRCP,…

VAI DEFAULT HEADER
September 24, 2017 Van Andel Research Institute hosts unique symposium on Parkinson’s disease

Grand Rapids, Mich. (Sept. 25, 2017)—Leading Parkinson’s experts and advocates from around the world will gather at Van Andel Research Institute in…

VAI DEFAULT HEADER
September 19, 2017 $2.375 million federal award to study epigenetic control systems, inform drug discovery

GRAND RAPIDS, MI (Sept. 20, 2017)—Van Andel Research Institute scientist Scott Rothbart, Ph.D., has been awarded a five-year, $2.375 million Maximizing…

VAI DEFAULT HEADER
June 12, 2017 VARI-SU2C Epigenetics Dream Team launches new clinical trial to combat blood cancers

GRAND RAPIDS, Mich. (June 13, 2017)—A new clinical trial spanning three cancer centers in California, Maryland and Pennsylvania is investigating a promising…